A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Pfister DG, McCaffrey J, Zahalsky AJ, Schwartz GK, Lis E, Gerald W, Huvos A, Shah J, Kraus D, Shaha A, Singh B, Wolden S, Zelefsky M, Palgi I.
Pfister DG, et al. Among authors: huvos a.
Invest New Drugs. 2002 Feb;20(1):123-7. doi: 10.1023/a:1014449309165.
Invest New Drugs. 2002.
PMID: 12003188
Clinical Trial.